万维提示：
1、该刊只有国际刊号。
2、投稿方式：官网投稿。
3、官网网址：
https://journal.hep.com.cn/ent/EN/home
4、投稿系统：
https://mc.manuscriptcentral.com/entdiscovery
5、官网电话：021-64377134
6、官网邮箱：entdiscovery@fudan.edu.cn
7、出刊日期：官方暂未公布刊期信息。
2025年11月25日星期二
Guidelines for authors
【官网信息】
ENT Discovery
Guidelines for authors
1 General Introduction
ENT Discovery (ENTD) is a dynamic platform dedicated to pioneering research and clinical innovations in otorhinolaryngology. The journal champions an interdisciplinary approach, integrating cutting-edge technologies, novel therapies, and surgical advancements to drive the field forward. We welcome original discoveries, translational studies, and clinical insights that advance the diagnosis and treatment of ENT disorders. For more information about the journal’s focus and coverage, please refer to the Aims & Scope. The journal is published online. Online versions are available at https://journal.hep.com.cn/ent.
2 Publication Ethics and Integrity
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/entdiscovery.
For help with submissions, please contact: entdiscovery@pub.hep.cn
2.1 Types of articles
l Original Article
Original Articles present novel research findings or conceptual analyses that make a substantial contribution to the field’s knowledge base.
l Review
Review Articles provide a comprehensive synthesis of developments in a field or current lines of thought, drawing on multiple sources of information and extensive referencing; the emphasis is on factual analysis rather than purely opinion.
l Case Report
Case Reports describe the detailed clinical presentation, diagnosis, treatment and follow-up of an individual patient (or a small case series) and typically highlight an unusual or novel occurrence or provide substantial learning value for the readership.
l Guideline
Guideline Articles provide evidence-based analyses and recommendations on issues relevant to clinical practice, health care management, public health or health policy.
l Perspective
Perspective Articles offer a forum for authors to present models, ideas or viewpoints on a specific area, typically reflecting personal insight or future directions rather than primary research.
l Commentary
Commentary Articles are evidence-based opinion pieces on topics of broad interest, often invited, providing critique, commentary or interpretation rather than original data.
l News
News items provide factual, timely information and updates on relevant events, research highlights or developments outside the primary peer-reviewed article structure.
l Editorial
Editorials are short pieces written by the Editor-in-Chief or a commissioned guest, conveying an opinion or overview on an issue of topical or strategic relevance to the journal and its readership.
2.2 Submission Requirements
l Type Select the appropriate article type according to “2.1 Types of articles”. Ensure that the content and structure of your manuscript align with the selected article type.
l Title Provide a concise and informative title reflecting the content and key findings of the manuscript. Avoid abbreviations and formulae where possible.
l Abstract The abstract should briefly summarize the objectives, methods, main results, and conclusions of the study. It must be self-contained and should not contain references or undefined abbreviations.
l Files All manuscript files must be clearly named and uploaded to their corresponding sections. Ensure that the file names indicate their content (e.g., “Figure 1,” “Table 2,” “Supplementary file”). Files include the several following types:
l Main Document The main text should be uploaded as a Microsoft Word (.doc or .docx) file. It should include the title, abstract, keywords, main text, references, and figure/table legends. Further details regarding manuscript structure and ethical standards can be found in the “Ethical requirements” section.
l Figure should be of high resolution (at least 300 dpi) and submitted as separate files in TIFF, JPEG, or PNG format. Each figure must be clearly numbered and cited in the text. Composite figures should be labeled (A, B, C…) consistently. Please include figure titles or legends in the Main Document.
l Table Tables should be included in the Main Document or uploaded separately in Word or Excel format. Use clear, concise titles and include explanatory footnotes when necessary. Each table must be clearly numbered and cited in the text. Please include table titles or legends in the Main Document.
l Supplemental file for Review Supplementary materials intended for review (e.g., additional data, methods, or figures) should be uploaded in this section. These files will be accessible to reviewers but may not appear in the final publication.
l Supplemental file NOT for Review Confidential materials (e.g., conflict of interest forms, or ethical approval documents) should be uploaded here. These will not be shared with reviewers.
l Title Page A separate title page should include the following:
1. Full title of the manuscript
2. Running title
3. Full names of all authors and their institutional affiliations
4. Corresponding author’s name, address, and e-mail
l Keywords Provide 3–8 keywords that accurately reflect the topic of the manuscript. Use terms that are searchable and standardized.
l Authors & Institutions List all authors in the correct order with their institutional affiliations, department names, city, and country.
Example format:
Author’s name, Department of Otorhinolaryngology, Head and Neck Surgery, [Institution Name], [City], [Country]
Corresponding author’s name, Department of Otorhinolaryngology, Head and Neck Surgery, [Institution Name], [City] [Postal Code], [Country], E-mail: email address.
l Reviewers Authors are encouraged to recommend or oppose up to three potential reviewers who have relevant expertise and no conflicts of interest. Please include each reviewer’s name, e-mail address, institution, department, and phone number. The final selection of reviewers rests with the Editorial Office.
l Details & Comments
l Cover Letter A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.
The cover letter must contain:
i) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium;
ii) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in;
iii) a statement confirming that all authors are in agreement with the content of the manuscript.
l Funding Is there funding to report for this submission? If yes, please choose “Yes” provide information on all sources of financial support, including name, grant/award numbers and funding agencies. If no specific funding was received, please choose “No”.
l Manuscript Details Enter general information such as Number of words, Number of manuscript pages, Number of tables, and Total number of figures. Authors should ensure that the selected article type matches the content and structure of the submission.
l Submission Information Confirm that the manuscript has been submitted solely to this journal and is not published, in press, or submitted elsewhere.
l Conflict of Interest ENT Discovery requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise, that might be perceived as influencing an author’s objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or indirectly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include but are not limited to patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker’s fees from a company. The existence of a conflict of interest does not preclude publication in this journal.
If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and to collectively list in the cover letter (if applicable) to the Editor-in-Chief, in the manuscript (in the footnotes, Conflict of Interest or Acknowledgments section), and in the online submission system ALL pertinent commercial and other relationships.
l Previously Submitted Has this manuscript previously
- been submitted via this submission website and received a revision decision [revised papers should be submitted as “revisions” and not as “new” papers]
- been submitted outside of this website and is now being submitted after revision
- been submitted to this publication and been rejected?
If any of the above is true please answer "Yes". If yes, please state previous Manuscript ID in the ‘Previously Submitted Field’ of the ScholarOne system.
l Author License Agreement(s) Confirm that all authors of this submission have understood the journal's licensing policy. Further information about the journal's license agreement(s) and Terms of Use can be found in 2.4 Copyright & OA Licensing in following part and Editorial policy.
2.3 Duplicate Publication and Plagiarism
We only accept original, unpublished manuscripts that have not been submitted simultaneously to other journals. By submitting a manuscript, authors agree to this policy. As defined by the World Association of Medical Editors (WAME), plagiarism is the use of others' published or unpublished ideas, words, or other intellectual property without attribution or permission. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies whether the material is taken from abstracts, research grants, or published or unpublished manuscripts. The editorial office uses plagiarism detection software, such as iThenticate, to screen all submissions. Any allegations of plagiarism are investigated in accordance with the Committee on Publication Ethics (COPE) guidelines. If plagiarism is detected at any point, appropriate actions will be taken, which may include notifying the authors' institution and funding agencies, and potentially retracting the published paper. For additional information, please visit http://www.publicationethics.org.
2.4 After Acceptance
l First Look
After your paper is accepted, your files will be assessed by the editorial office to ensure they are ready for production. You may be contacted if any updates or final files are required. Otherwise, your paper will be sent to the production team.
l Copyright & OA Licensing
ENT Discovery is an open access journal. All articles published in this journal are freely and permanently available online immediately upon publication. Readers are allowed to read, download, copy, distribute, print, search, or link to the full texts of articles without prior permission from the publisher or the author. All published articles are licensed under the Creative Commons Attribution License (CC-BY).This license permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Authors retain the copyright of their work. For more information, please visit https://creativecommons.org/licenses/by/4.0/. Note that certain funders mandate a particular type of CC license be used. For more information on this journal’s APCs, please see Open Access in “Editorial Policy”.
Upon acceptance, authors are required to complete the OA Agreement to confirm the transfer of publishing rights and acknowledge the terms of the CC BY license. Authors should ensure that all listed co-authors have approved the final version of the manuscript and agree to its submission.
OA Agreement Procedure:
1. After your manuscript has been accepted, please log into the ScholarOne Manuscripts system.
2. Download the original OA Agreement file provided in your author center.
3. Print and sign the document (an electronic signature is acceptable).
4. Upload the signed agreement (PDF or scanned copy) to the designated section in ScholarOne to complete the authorization process.
Failure to complete this step may result in a delay in publication.
For further information or assistance, please contact the editorial office at entdiscovery@pub.hep.cn.
l Proofs
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online/with their proofs included as a pdf. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 72 hours of receipt of the email.
Pubdate: Jul 18, 2025
